Verastem (VSTM) Operating Income Growth (3y) (2014 - 2026)
Verastem (VSTM) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 55.96% |
| 10 | Verastem | 625.63 Mn | 427.80 Mn | 15.90 Mn | -32.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.40% |
| Dec 31, 2025 | -35.03% |
| Sep 30, 2025 | -31.98% |
| Jun 30, 2025 | -26.93% |
| Mar 31, 2025 | -37.53% |
| Dec 31, 2024 | -24.14% |
| Sep 30, 2024 | -35.62% |
| Jun 30, 2024 | -4.66% |
| Mar 31, 2024 | -25.76% |
| Dec 31, 2023 | -22.95% |
| Sep 30, 2023 | -50.65% |
| Jun 30, 2023 | 1.55% |
| Mar 31, 2023 | 9.80% |
| Dec 31, 2022 | 20.31% |
| Sep 30, 2022 | 12.13% |
| Jun 30, 2022 | 17.62% |
| Mar 31, 2022 | 21.18% |
| Dec 31, 2021 | 21.60% |
| Sep 30, 2021 | 11.71% |
| Jun 30, 2021 | 4.30% |